CAR-T細胞治療薬の世界市場見通し2023年-2029年

◆英語タイトル:CAR T-cell Therapy Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23LY8391)◆商品コード:MMG23LY8391
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年7月
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global CAR T-cell Therapy Drug Market 調査レポートは次の情報を含め、グローバルにおけるのCAR-T細胞治療薬市場規模と予測を収録しています。・世界のCAR-T細胞治療薬市場:売上、2018年-2023年、2024年-2029年
・世界のCAR-T細胞治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のCAR-T細胞治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CD19標的」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

CAR-T細胞治療薬のグローバル主要企業は、Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKiteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、CAR-T細胞治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のCAR-T細胞治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のCAR-T細胞治療薬市場:タイプ別市場シェア、2022年
・CD19標的、BCMA標的

世界のCAR-T細胞治療薬市場:用途別、2018年-2023年、2024年-2029年
世界のCAR-T細胞治療薬市場:用途別市場シェア、2022年
・リンパ腫、多発性骨髄腫

世界のCAR-T細胞治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のCAR-T細胞治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるCAR-T細胞治療薬のグローバル売上、2018年-2023年
・主要企業におけるCAR-T細胞治療薬のグローバル売上シェア、2022年
・主要企業におけるCAR-T細胞治療薬のグローバル販売量、2018年-2023年
・主要企業におけるCAR-T細胞治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKite

*************************************************************

・調査・分析レポートの概要
CAR-T細胞治療薬市場の定義
市場セグメント
世界のCAR-T細胞治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のCAR-T細胞治療薬市場規模
世界のCAR-T細胞治療薬市場規模:2022年 VS 2029年
世界のCAR-T細胞治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのCAR-T細胞治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のCAR-T細胞治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:CD19標的、BCMA標的
CAR-T細胞治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:リンパ腫、多発性骨髄腫
CAR-T細胞治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別CAR-T細胞治療薬市場規模 2022年と2029年
地域別CAR-T細胞治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKite
...

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
This report aims to provide a comprehensive presentation of the global market for CAR T-cell Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-cell Therapy Drug. This report contains market size and forecasts of CAR T-cell Therapy Drug in global, including the following market information:
Global CAR T-cell Therapy Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CAR T-cell Therapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR T-cell Therapy Drug include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR T-cell Therapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-cell Therapy Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, by Type, 2022 (%)
CD19-targeted
BCMA-targeted
Global CAR T-cell Therapy Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global CAR T-cell Therapy Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CAR T-cell Therapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-cell Therapy Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR T-cell Therapy Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-cell Therapy Drug, market overview.
Chapter 2: Global CAR T-cell Therapy Drug market size in revenue.
Chapter 3: Detailed analysis of CAR T-cell Therapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-cell Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 CAR T-cell Therapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-cell Therapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-cell Therapy Drug Overall Market Size
2.1 Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029
2.2 Global CAR T-cell Therapy Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-cell Therapy Drug Players in Global Market
3.2 Top Global CAR T-cell Therapy Drug Companies Ranked by Revenue
3.3 Global CAR T-cell Therapy Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR T-cell Therapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-cell Therapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-cell Therapy Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR T-cell Therapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global CAR T-cell Therapy Drug Market Size Markets, 2022 & 2029
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type – Global CAR T-cell Therapy Drug Revenue & Forecasts
4.2.1 By Type – Global CAR T-cell Therapy Drug Revenue, 2018-2023
4.2.2 By Type – Global CAR T-cell Therapy Drug Revenue, 2024-2029
4.2.3 By Type – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application – Global CAR T-cell Therapy Drug Revenue & Forecasts
5.2.1 By Application – Global CAR T-cell Therapy Drug Revenue, 2018-2023
5.2.2 By Application – Global CAR T-cell Therapy Drug Revenue, 2024-2029
5.2.3 By Application – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global CAR T-cell Therapy Drug Market Size, 2022 & 2029
6.2 By Region – Global CAR T-cell Therapy Drug Revenue & Forecasts
6.2.1 By Region – Global CAR T-cell Therapy Drug Revenue, 2018-2023
6.2.2 By Region – Global CAR T-cell Therapy Drug Revenue, 2024-2029
6.2.3 By Region – Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America CAR T-cell Therapy Drug Revenue, 2018-2029
6.3.2 US CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.3 Canada CAR T-cell Therapy Drug Market Size, 2018-2029
6.3.4 Mexico CAR T-cell Therapy Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe CAR T-cell Therapy Drug Revenue, 2018-2029
6.4.2 Germany CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.3 France CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.4 U.K. CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.5 Italy CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.6 Russia CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.7 Nordic Countries CAR T-cell Therapy Drug Market Size, 2018-2029
6.4.8 Benelux CAR T-cell Therapy Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia CAR T-cell Therapy Drug Revenue, 2018-2029
6.5.2 China CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.3 Japan CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.4 South Korea CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.5 Southeast Asia CAR T-cell Therapy Drug Market Size, 2018-2029
6.5.6 India CAR T-cell Therapy Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America CAR T-cell Therapy Drug Revenue, 2018-2029
6.6.2 Brazil CAR T-cell Therapy Drug Market Size, 2018-2029
6.6.3 Argentina CAR T-cell Therapy Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa CAR T-cell Therapy Drug Revenue, 2018-2029
6.7.2 Turkey CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.3 Israel CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.4 Saudi Arabia CAR T-cell Therapy Drug Market Size, 2018-2029
6.7.5 UAE CAR T-cell Therapy Drug Market Size, 2018-2029
7 CAR T-cell Therapy Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-cell Therapy Drug Major Product Offerings
7.1.4 Novartis CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-cell Therapy Drug Major Product Offerings
7.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-cell Therapy Drug Major Product Offerings
7.4.4 J & J CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-cell Therapy Drug Major Product Offerings
7.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-cell Therapy Drug Major Product Offerings
7.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. CAR T-cell Therapy Drug Market Opportunities & Trends in Global Market
Table 2. CAR T-cell Therapy Drug Market Drivers in Global Market
Table 3. CAR T-cell Therapy Drug Market Restraints in Global Market
Table 4. Key Players of CAR T-cell Therapy Drug in Global Market
Table 5. Top CAR T-cell Therapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-cell Therapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-cell Therapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-cell Therapy Drug Product Type
Table 9. List of Global Tier 1 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-cell Therapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-cell Therapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-cell Therapy Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-cell Therapy Drug Product Offerings
Table 32. Novartis CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-cell Therapy Drug Product Offerings
Table 36. Gilead Sciences CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offerings
Table 40. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-cell Therapy Drug Product Offerings
Table 44. J & J CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-cell Therapy Drug Product Offerings
Table 48. JW Therapeutics CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-cell Therapy Drug Product Offerings
Table 52. FOSUNKite CAR T-cell Therapy Drug Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
List of Figures
Figure 1. CAR T-cell Therapy Drug Segment by Type in 2022
Figure 2. CAR T-cell Therapy Drug Segment by Application in 2022
Figure 3. Global CAR T-cell Therapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-cell Therapy Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CAR T-cell Therapy Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-cell Therapy Drug Revenue in 2022
Figure 8. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global CAR T-cell Therapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 16. US CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 20. Germany CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 28. China CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 34. Brazil CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CAR T-cell Therapy Drug Revenue Market Share, 2018-2029
Figure 37. Turkey CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CAR T-cell Therapy Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite CAR T-cell Therapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ CAR-T細胞治療薬の世界市場見通し2023年-2029年(CAR T-cell Therapy Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆